Doxycycline Inducible Chimeric Antigen Receptor T Cells Targeting CD147 for Hepatocellular Carcinoma Therapy

Chimeric antigen receptor T cell (CAR-T) therapy to hematological malignancies has demonstrated tremendous clinical outcomes. However, the therapeutic efficacy of CAR-T cells in solid tumors remains limited due to the scarcity of tumor-specific antigen targets and the poor infiltration of CAR-T cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ren-Yu, Wei, Ding, Liu, Ze-Kun, Yong, Yu-Le, Wei, Wei, Zhang, Zhi-Yun, Lv, Jian-Jun, Zhang, Zhao, Chen, Zhi-Nan, Bian, Huijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798074/
https://www.ncbi.nlm.nih.gov/pubmed/31681766
http://dx.doi.org/10.3389/fcell.2019.00233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798074/
https://www.ncbi.nlm.nih.gov/pubmed/31681766
http://dx.doi.org/10.3389/fcell.2019.00233

Ejemplares similares